homocysteine and drospirenone

homocysteine has been researched along with drospirenone in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beretta, L; Caronni, M; Scorza, R	1
Battaglia, C; Busacchi, P; Cianciosi, A; Facchinetti, F; Mancini, F; Persico, N	1
Bart, S; Diefenbach, K; Marr, J; Sampson-Landers, C; Trummer, D	1
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L	1

Trials

2 trial(s) available for homocysteine and drospirenone

Article	Year
Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study. Contraception, 2012, Volume: 85, Issue:1 Topics: Adolescent; Adult; Androstenes; Calcium; Contraceptives, Oral; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Homocysteine; Humans; Mineralocorticoid Receptor Antagonists; Neural Tube Defects; Treatment Outcome; Young Adult	2012
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3 Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult	2018

Article

Year

Folate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter study.

Contraception, 2012, Volume: 85, Issue:1

Topics: Adolescent; Adult; Androstenes; Calcium; Contraceptives, Oral; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Folic Acid; Glutamates; Homocysteine; Humans; Mineralocorticoid Receptor Antagonists; Neural Tube Defects; Treatment Outcome; Young Adult

2012

The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study.

Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3

Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult

2018

Other Studies

2 other study(ies) available for homocysteine and drospirenone

Article	Year
Systemic sclerosis following oral contraception. Clinical rheumatology, 2005, Volume: 24, Issue:3 Topics: Adult; Androstenes; Antibodies, Antinuclear; Biomarkers; Centromere; Diagnosis, Differential; Female; Follow-Up Studies; Homocysteine; Humans; Menstruation Disturbances; Microscopic Angioscopy; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Scleroderma, Systemic	2005
Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study. American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2 Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome	2010

Article

Year

Systemic sclerosis following oral contraception.

Clinical rheumatology, 2005, Volume: 24, Issue:3

Topics: Adult; Androstenes; Antibodies, Antinuclear; Biomarkers; Centromere; Diagnosis, Differential; Female; Follow-Up Studies; Homocysteine; Humans; Menstruation Disturbances; Microscopic Angioscopy; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Scleroderma, Systemic

2005

Drospirenone and cardiovascular risk in lean and obese polycystic ovary syndrome patients: a pilot study.

American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:2

Topics: Adolescent; Adult; Androstenes; Brachial Artery; Cardiovascular Diseases; Contraceptives, Oral; Endothelin-1; Female; Homocysteine; Humans; Insulin; Insulin Resistance; Leptin; Mineralocorticoid Receptor Antagonists; Obesity; Pilot Projects; Polycystic Ovary Syndrome

2010